Skip to main content
Log in

Activation of caspase-8 is critical for sensitivity to cytotoxic anti-Fas antibody-induced apoptosis in human ovarian cancer cells

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Two ovarian cancer cell lines named NOS4 and SKOV-3 have been shown to have different sensitivities to a cytotoxic anti-Fas antibody, CH-11. Although both cell lines express Fas molecules on the cell surfaces at the same intensities, apoptosis is induced by CH-11 in NOS4 cells but not in SKOV-3 cells. In this study, the different apoptosis-sensitivities of these cells were assessed. Both cell lines express almost the same levels of FADD, RIP, c-FLIP, FAP-1, Bax, Bcl-2 and Bcl-XL. Evidence of caspase-8, caspase-9 and caspase-3 activation and of cleavage of PARP and Bid was obtained in NOS4 cells but not in SKOV-3 cells. When triggered by FasL protein, DNA fragmentation and caspase-8 activation were observed in SKOV-3 cells, though they were not as clear as in NOS4 cells. All the anti-Fas antibody-mediated signals for apoptosis induction in NOS4 cells were completely blocked by a caspase-8-specific inhibitor, Z-IETD-FMK. These results indicate that the different sensitivities to the anti-Fas antibody are solely dependent on the activation of caspase-8, which could be influenced by yet unknown qualitative or quantitative abnormalities in molecules involved in DISC formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kerr JFR, Wyllie AH, Currie AR Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–257.

    Google Scholar 

  2. Tanuma S Molecular mechanisms of apoptosis. In: Sluyser M., ed. Apoptosis in Normal Development and Cancer. London, UK: Taylor & Francis 1996: 39–59.

    Google Scholar 

  3. Yonehara S, Ishii A, Yonehara M, et al A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169: 1747–1756.

    Google Scholar 

  4. Suda T, Takahashi T, Glstein P, et al Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169–1178.

    Google Scholar 

  5. Suda T, Okazaki T, Naito Y, et al Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154: 3806–3813.

    Google Scholar 

  6. Ormerod MG, Neil CE, Robertson D, et al Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp Cell Res 1994; 211: 231–237.

    Google Scholar 

  7. Wakahara Y, Nawa A, Hayakawa A, et al Combination effect of anti-Fas antibody and chemotherapeutic drugs in ovarian cancer cells in vitro. Oncology 1997; 54: 48–54.

    Google Scholar 

  8. Hayakawa A, Yokoyama I, Tajiri H, et al Protein kinase Cdependent anti-apoptotic mechanism that is associated with high sensitivity to anti-Fas antibody in ovarian cancer cell lines. Cancer Letters 1999; 140: 113–119.

    Google Scholar 

  9. Schneider P, Holler N, Bodmer JL, et al Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998; 187: 1205–1213.

    Google Scholar 

  10. Herrmann M, Lorenz HM, Voll R, et al A rapid simple method for the isolation of apoptotic DNA fragments. Nuclei Acids Res 1994; 22: 5506–5507.

    Google Scholar 

  11. Shiokawa D, Ohyama H, Yamada T, et al Identification of an endonuclease responsible for apoptosis in rat thymocytes. Eur J Biochem 1994; 226: 23–30.

    Google Scholar 

  12. Sato T, Irie S, Kitada S, et al FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 1995; 268: 411–415.

    Google Scholar 

  13. Nakashima I, Zhang YH, Rahmn SM, et al Evidence of synergy between Thy-1 and CD3/TCR complex in signal delivery to murine thymocytes for cell death. J Immunol 1991; 147: 1153–1162.

    Google Scholar 

  14. Baker SJ, Reddy EP.Transducers of life and death:TNFreceptor superfamily and associated proteins. Oncogene 1996; 12: 1–9.

    Google Scholar 

  15. Baker SJ, Reddy EP Modulation of life and death by the TNF receptor superfamily. Oncogene 1998; 17: 3261–3270.

    Google Scholar 

  16. Krueger A, Schmitz I, Baumann S, et al c-FLIP splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex (DISC). J Biol Chem, in press.

  17. Nakai Y, Irie S, Sato T Identification of IκBα as a substrate of Fas-associated phosphatase-1. Eur J Biochem 2000; 267: 7170–7175.

    Google Scholar 

  18. Fuchs J, Karen A, Mckenna KA, Atul B P53-dependent DNA damage-induced apoptosis requires Fas/APO-1 independent activation of CPP32β. Cancer Res 1997; 57: 2550–2554.

    Google Scholar 

  19. Nishimura Y, Ishii A, Kobayashi Y, et al Expression and function of Fas antigen on immature and mature T cells. J Immunol 1995; 154. 4395–4403.

    Google Scholar 

  20. Hirata H, Takahashi A, Kobayashi S, et al Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med 1998; 187: 587–600.

    Google Scholar 

  21. Srinivasula SM, Ahmad M, Frenandes-Alnemri T, et al Autoactivation of procaspase-9 by apaf-1 mediated oligomerization. Mol Cell 1998;1: 949–957.

    Google Scholar 

  22. Jeong E, Bang S, Ho-Lee T, et al The solution structure of FADD death domain. J Bio Chem 1999; 274: 16337–16342.

    Google Scholar 

  23. Stanger BZ, Leder P, Lee TH, et al RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 1995; 81: 513–523.

    Google Scholar 

  24. Chinnaiyan AM, O'Rourke K, Tewari M, et al FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995; 81: 505–512.

    Google Scholar 

  25. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas antigenmediated cell death. J Immunol 1993; 151: 621–627.

    Google Scholar 

  26. Wang K, Yin XM, Chao DT: BID: A novel BH-3 domain-only death agonist. Genes & Develop 1996; 10: 2859–2869.

    Google Scholar 

  27. Li H, Zhu H, Xu C, et al Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491–501

    Google Scholar 

  28. Horiuchi T, Himeji D, Tsukamoto H, et al Dominant expression of a novel splice variant of caspase-8 in human peripheral blood lymphocytes. Biochem Biophys Res Commun 2000; 272: 877–881.

    Google Scholar 

  29. Wolf B, Schuler M, Li W, et al Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity. J Biol Chem 2001; 276: 34244–34251.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayakawa, A., Wu, J., Kawamoto, Y. et al. Activation of caspase-8 is critical for sensitivity to cytotoxic anti-Fas antibody-induced apoptosis in human ovarian cancer cells. Apoptosis 7, 107–113 (2002). https://doi.org/10.1023/A:1014302212321

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014302212321

Navigation